Clinical Trial Update: AZD6738 for Patients With Progressive MDS or CMML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of AZD6738 in patients with progressive myelodysplastic syndrome or chronic myelomonocytic leukemia; the study is active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• AZD6738 (ceralasertib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: ACTIVE_NOT_RECRUITING